Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/15/17 → 2/15/23 |
Funding
- PPD Investigator Services, LLC ((OE) Prot #AG-221-AML-005 // (OE) Prot #AG-221-AML-005)
- Celgene Corporation ((OE) Prot #AG-221-AML-005 // (OE) Prot #AG-221-AML-005)
Prot #AG-221-AML-005: A Phase 1B/2 Open-Label, Randomized Study of 2 Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine: Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus SC Azacitidine in Subjects With
- Frankfurt, Olga (PD/PI)
Project: Research project